Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background: Diagnosing dengue accurately, especially in resource-limited settings, remains challenging due to overlapping symptoms with other febrile illnesses and limitations of current diagnostic methods. This study aimed to develop machine learning (ML) models that leverage readily available clinical data to improve diagnostic accuracy for dengue, potentially offering a more accessible and rapid diagnostic tool for healthcare providers. Methods: We used data from the Sentinel Enhanced Dengue Surveillance System (SEDSS) in Puerto Rico (May 2012-June 2024). SEDSS primarily targets acute febrile illness but also includes cases with other symptoms during outbreaks (e.g., Zika and COVID-19). ML models (logistic regression, random forest, support vector machine, artificial neural network, adaptive boosting, light gradient boosting machine [LightGBM], and extreme gradient boosting [XGBoost]) were evaluated across different feature sets, including demographic, clinical, laboratory, and epidemiological variables. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), where higher AUC values indicate better performance in distinguishing dengue cases from non-dengue cases. Results: Among 49,679 patients in SEDSS, 1,640 laboratory-confirmed dengue cases were identified. The XGBoost and LightGBM models achieved the highest diagnostic accuracy, with AUCs exceeding 90%, particularly with comprehensive feature sets. Incorporating predictors such as monthly dengue incidence, leukopenia, thrombocytopenia, rash, age, and absence of nasal discharge significantly enhanced model sensitivity and specificity for diagnosing dengue. Adding more relevant clinical and epidemiological features consistently improved the models' ability to correctly identify dengue cases. Conclusions: ML models, especially XGBoost and LightGBM, show promise for improving diagnostic accuracy for dengue using widely accessible clinical data, even in resource-limited settings. Future research should focus on developing user-friendly tools, such as mobile apps, web-based platforms, or clinical decision systems integrated into electronic health records, to implement these models in clinical practice and exploring their application for predicting dengue.
Background: Diagnosing dengue accurately, especially in resource-limited settings, remains challenging due to overlapping symptoms with other febrile illnesses and limitations of current diagnostic methods. This study aimed to develop machine learning (ML) models that leverage readily available clinical data to improve diagnostic accuracy for dengue, potentially offering a more accessible and rapid diagnostic tool for healthcare providers. Methods: We used data from the Sentinel Enhanced Dengue Surveillance System (SEDSS) in Puerto Rico (May 2012-June 2024). SEDSS primarily targets acute febrile illness but also includes cases with other symptoms during outbreaks (e.g., Zika and COVID-19). ML models (logistic regression, random forest, support vector machine, artificial neural network, adaptive boosting, light gradient boosting machine [LightGBM], and extreme gradient boosting [XGBoost]) were evaluated across different feature sets, including demographic, clinical, laboratory, and epidemiological variables. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), where higher AUC values indicate better performance in distinguishing dengue cases from non-dengue cases. Results: Among 49,679 patients in SEDSS, 1,640 laboratory-confirmed dengue cases were identified. The XGBoost and LightGBM models achieved the highest diagnostic accuracy, with AUCs exceeding 90%, particularly with comprehensive feature sets. Incorporating predictors such as monthly dengue incidence, leukopenia, thrombocytopenia, rash, age, and absence of nasal discharge significantly enhanced model sensitivity and specificity for diagnosing dengue. Adding more relevant clinical and epidemiological features consistently improved the models' ability to correctly identify dengue cases. Conclusions: ML models, especially XGBoost and LightGBM, show promise for improving diagnostic accuracy for dengue using widely accessible clinical data, even in resource-limited settings. Future research should focus on developing user-friendly tools, such as mobile apps, web-based platforms, or clinical decision systems integrated into electronic health records, to implement these models in clinical practice and exploring their application for predicting dengue.
In this research, an advanced artificial neural network (ANN)-based approach for prognosis and classification of dengue disease is presented. Dengue diagnosis usually relies on clinical assessment; subsequently, there might be a high probability of misdiagnoses due to the complex hodgepodge of symptoms of dengue with other vector-borne diseases. It is needed to develop a system that can help doctors to identify dengue disease much faster than the manual system, which takes longer time and more cost to detect the diseases. Such a system may help users to take an early action before it becomes serious. The study involved three phases: pre-processing, neural network processing, and post-processing. In the pre-processing phase, data were gathered from three high-severity dengue outbreak sites in Pakistan (Benazir Bhutto Hospital, CITI Lab Rawalpindi, and Meo Hospital Lahore) where the dengue outbreak severity was high during the year of 2011. After cleaning and normalizing, 768 samples were obtained, split into 560 for training and 208 for testing. Nineteen critical parameters were selected with input from physicians, medical staff, and prior research. This study presents a supervised feed-forward neural network (FFNN) with two hidden layers, trained using backpropagation and optimized with the Levenberg-Marquardt algorithm, achieving nearly 100% accuracy, minimal runtime, and a very low MSE (0.00000000000032521). The model reached 100% sensitivity, 99.8% precision, and 98.7% specificity, surpassing prior results in dengue diagnosis. The findings support improved diagnostic accuracy and confidence, providing a framework for physicians. Key factors in achieving optimal results include careful selection of architecture, data normalization, parameter selection, and critical evaluation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.